Instruction for use: Immunoglobulin complex preparation (TRC)

Dosage form: Lyophilizate for solution for oral administration; Substance is thick

Active substance: Immunoglobulinum humanum normale

ATX

J06BA Normal human immunoglobulin

Pharmacological group:

Immunoglobulins

The nosological classification (ICD-10)

D84.9 Unspecified Immunodeficiency: Pneumonia in immunodeficient states; Autoimmune disease; Autoimmune diseases; Severe immunodeficiency; immune deficiency; Immunodeficiency; immunodeficiency diseases; Immunodeficiency states due to surgery; Immunotherapy for cancer; Immunomodulation; Infections in patients with weakened immune systems; Correction of immune deficiency; Correction of immunodeficiencies; Correction of a weakened immune system; Correction of a weakened immunity in immunodeficient states; Violation of immunity; Violation of the immune status; Immune System Disorders; Primary immunodeficiency; Maintaining immunity; Lowering the body's defenses; Lowering the immunity; Lowering the immunity of colds and infectious diseases; The decrease of the immune status; Lowered resistance to infections; Lowered resistance to infections and colds; Lowered resistance; Immunosuppression; Predisposition to colds; acquired immune deficiencies; Radiation immunodeficiency; The development of immunodeficiency; Immune dysfunction syndrome; immunodeficiency syndrome; primary immunodeficiency syndrome; Reducing the body's defenses; Immunosuppression; Reduced immune defense; Reducing local immunity; Reducing the total body resistance; The decrease in cell-mediated immunity; Reduced resistance to infections in children; Reducing the body's resistance; Reduced resistance; reduced immunity; Status immunodeficiency; Stimulation of the processes of nonspecific immunity; Heavy selective secondary immunodeficiency; immunity Oppression; Primary immunodeficiency

K63.8.0 * Dysbacteriosis: Intestinal lymphangiectasia

Z29.1 Prophylactic immunotherapy: Vaccination against viral infections; donor Vaccination; Vaccination and revaccination; Vaccination of newborns; Vaccination against hepatitis B; Immunization; Correction of the immune status; Therapeutic and prophylactic immunization; Preventive immunization; Specific immunoprophylaxis; Stimulation of the processes of nonspecific immunit

Z54 recovery period: The recovery period; The recovery period after illness; Recovery; The recovery from the flu and colds; Recovery after illness; The lack of mineral salts in the period of convalescence; The period of recovery after illness; The period of recovery after illness and surgery; The period of recovery after a serious illness; The period of convalescence after illness; rehabilitation period; rekovalestsentsii period after infectious diseases; decubation; The period of convalescence after surgery and infectious diseases; The period of convalescence after prolonged infections; The period of convalescence after serious diseases; The period of convalescence after severe infections; Rehabilitation period; convalescent state; Convalescence after illness; Convalescence after infectious diseases; Convalescence after debilitating diseases; Convalescence after infectious diseases; Convalescence at an elevated blood loss; Status of convalescence after illness

Composition and release form

1 bottle with lyophilized powder for oral solution contains immunoglobulin 300 mg (1 dose); In the package of 5 pcs., In a cardboard box.

Pharmachologic effect

Mode of action - immunostimulating.

It increases specific immunity, increases the content of immunoglobulins and antibodies to enterobacteria (shigella, salmonella, escherichia, etc.).

Indication of the Immunoglobulin complex preparation (TRC)

Acute intestinal infections, dysbacteriosis (after exposure to radiation, chemotherapy), the prevention of infectious diseases in people with acquired immunodeficiency, immunocorrective therapy in children of the first years of life (premature, weakened, fed on artificial feeding) and persons with a reduced immune status (disabled, elderly) .

Contraindications

Allergic reaction (Quincke's edema, rash, anaphylactic shock) on the introduction of human immunoglobulin in history.

Side effects

Polymorphic rashes.

Interaction

Possible combination with antibiotics, synthetic chemotherapeutic drugs, bacteriophages.

Dosing and Administration

Inside, 30 minutes before meals (previously diluted powder in boiled water at room temperature: to the contents of the bottle add water to half the volume and mix with light shaking until a colorless transparent liquid is obtained - opalescence is allowed) 1-2 times a day for 5 days.

Special instructions

If there are polymorphic rashes, treatment can be continued under the cover of antihistamines. Each introduction is registered in the established accounting forms with the serial number, control number, expiration date, manufacturer, date of introduction and the nature of the response to the introduction.

Storage conditions of the drug Immunoglobulin complex preparation (TRC)

In dry, the dark place at a temperature of 2-10 ° C.

Keep out of the reach of children.

Shelf life of the drug Immunoglobulin complex preparation (TRC)

3 years.

Do not use after the expiry date printed on the package.